Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis

Abstract

Hepatitis C virus (HCV)-induced chronic liver disease is a leading cause of hepatocellular carcinoma (HCC). However, the molecular mechanisms underlying HCC development following chronic HCV infection remain poorly understood. MicroRNAs (miRNAs) play an important role in homeostasis within the liver, and deregulation of miRNAs has been associated with liver disease, including HCC. While host miRNAs are essential for HCV replication, viral infection in turn appears to induce alterations of intrahepatic miRNA networks. Although the cross talk between HCV and liver cell miRNAs most likely contributes to liver disease pathogenesis, the functional involvement of miRNAs in HCV-driven hepatocyte injury and HCC remains elusive. Here we combined a hepatocyte-like cell-based model system, high-throughput small RNA sequencing, computational analysis, and functional studies to investigate HCV-miRNA interactions that may contribute to liver disease and HCC. Profiling analyses indicated that HCV infection differentially regulated the expression of 72 miRNAs by at least 2-fold, including miRNAs that were previously described to target genes associated with inflammation, fibrosis, and cancer development. Further investigation demonstrated that the miR-146a-5p level was consistently increased in HCV-infected hepatocyte-like cells and primary human hepatocytes, as well as in liver tissue from HCV-infected patients. Genomewide microarray and computational analyses indicated that miR-146a-5p overexpression modulates pathways that are related to liver disease and HCC development. Furthermore, we showed that miR-146a-5p has a positive impact on late steps of the viral replication cycle, thereby increasing HCV infection. Collectively, our data indicate that the HCV-induced increase in miR-146a-5p expression both promotes viral infection and is relevant for pathogenesis of liver disease. IMPORTANCEHCV is a leading cause of chronic liver disease and cancer. However, how HCV induces liver cancer remains poorly understood. There is accumulating evidence that a viral cure does not eliminate the risk for HCC development. Thus, there is an unmet medical need to develop novel approaches to predict and prevent virus-induced HCC. miRNA expression is known to be deregulated in liver disease and cancer. Furthermore, miRNAs are essential for HCV replication, and HCV infection alters miRNA expression. However, how miRNAs contribute to HCV-driven pathogenesis remains elusive. Here we show that HCV induces miRNAs that may contribute to liver injury and carcinogenesis. The miR-146a-5p level was consistently increased in different cell-based models of HCV infection and in HCV patient-derived liver tissue. Furthermore, miR-146a-5p increased HCV infection. Collectively, our data are relevant to understanding viral pathogenesis and may open perspectives for novel biomarkers and prevention of virus-induced liver disease and HCC. H epatitis C virus (HCV) infection is a leading cause of chronic liver disease and hepatocellular carcinoma (HCC) worldw...

Hepatitis C Virus Mediated Inhibition of miR‐181c Activates ATM Signaling and Promotes Hepatocyte Growth

“…Other miRNAs, including miR-155, miR-146a-5p, miR-135a-5p and miR-373, were shown to either promote or inhibit HCV-associated hepatocarcinogenesis. (45)(46)(47)(48) Our study highlighted how intratumoral introduction of synthetic miR-181c inhibits tumor progression in a HCC xenograft tumor model. Recent introduction of direct-acting antivirals (DAAs) with the combinations of virus replication inhibitors may achieve a decrease in virus titer to a sustained virological response in HCV-infected patients.…”

miR‐146a‐5p: Expression, regulation, and functions in cancer

“…In a 2016 article, the authors observed an upregulation of miR-146a in HCV-infected hepatocytes and liver tissue from patients suffering from HCV. They also provided evidence for miR-146a's involvement in HCV replication, where the miRNA supported HCV infection of cells (Bandiera et al, 2016). Again, this concept needs to be explored further before any solid conclusions can be made.…”

Plasma microRNA: A novel non‑invasive biomarker for HBV‑associated liver fibrosis staging

“…Previous evidence has suggested that there is a complex association between miRNAs and HBV genes (29)(30)(31). The mechanism of HBV infection in regulating miRNAs may be through either RNA interference or the inhibition of translational initiation and elongation (23,(32)(33)(34). In addition, deregulated expression of miRNAs may be present for a long period prior to the onset of disease (35).…”